首页> 美国卫生研究院文献>ACS AuthorChoice >Identificationof Biologically Active HIV TAR RNA-BindingSmall Molecules Using Small Molecule Microarrays
【2h】

Identificationof Biologically Active HIV TAR RNA-BindingSmall Molecules Using Small Molecule Microarrays

机译:身份证明活性HIV TAR RNA结合的研究使用小分子微阵列的小分子

代理获取
本网站仅为用户提供外文OA文献查询和代理获取服务,本网站没有原文。下单后我们将采用程序或人工为您竭诚获取高质量的原文,但由于OA文献来源多样且变更频繁,仍可能出现获取不到、文献不完整或与标题不符等情况,如果获取不到我们将提供退款服务。请知悉。

摘要

Identifying small molecules that selectively bind to structured RNA motifs remains an important challenge in developing potent and specific therapeutics. Most strategies to find RNA-binding molecules have identified highly charged compounds or aminoglycosides that commonly have modest selectivity. Here we demonstrate a strategy to screen a large unbiased library of druglike small molecules in a microarray format against an RNA target. This approach has enabled the identification of a novel chemotype that selectively targets the HIV transactivation response (TAR) RNA hairpin in a manner not dependent on cationic charge. Thienopyridine >4 binds to and stabilizes the TAR hairpin with a Kd of 2.4 μM. Structure–activity relationships demonstrate that this compound achieves activity through hydrophobic and aromatic substituents on a heterocyclic core, rather than cationic groups typically required. Selective 2′-hydroxyl acylation analyzed by primer extension (SHAPE) analysis was performed on a 365-nucleotide sequence derived from the 5′ untranslatedregion (UTR) of the HIV-1 genome to determine global structural changesin the presence of the molecule. Importantly, the interaction of compound >4 can be mapped to the TAR hairpin without broadly disruptingany other structured elements of the 5′ UTR. Cell-based anti-HIVassays indicated that >4 inhibits HIV-induced cytopathicityin T lymphocytes with an EC50 of 28 μM, while cytotoxicitywas not observed at concentrations approaching 1 mM.
机译:鉴定选择性结合结构化RNA基序的小分子仍然是开发有效和特异性治疗剂的重要挑战。寻找RNA结合分子的大多数策略已经鉴定出通常具有中等选择性的带高电荷的化合物或氨基糖苷。在这里,我们展示了一种针对RNA靶点筛选微阵列格式的药物样小分子的大型无偏文库的策略。这种方法已经能够鉴定一种新型化学型,该化学型以不依赖阳离子电荷的方式选择性靶向HIV反式激活应答(TAR)RNA发夹。噻吩并吡啶> 4 以2.4μM的Kd结合并稳定TAR发夹。结构-活性关系表明,该化合物可通过杂环核心上的疏水和芳族取代基实现活性,而不是通常需要的阳离子基团。通过引物延伸(SHAPE)分析分析的选择性2'-羟基酰化反应是对源自5'非翻译产物的365个核苷酸序列进行的HIV-1基因组的区域(UTR)以确定整体结构变化在分子存在下。重要的是,化合物> 4 的相互作用可以映射到TAR发夹,而不会大范围破坏5'UTR的任何其他结构化元素。基于细胞的抗HIV分析表明> 4 抑制HIV诱导的细胞病变在EC50为28μM的T淋巴细胞中,同时具有细胞毒性在接近1 mM的浓度下未观察到。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
代理获取

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号